Personalised Vitamins Australia: The Ultimate Guide to Custom Nutrition

 

A 2022 Australian Bureau of Statistics survey found that approximately 75 percent of Australian adults take at least one supplement — yet the single most common consumer complaint about supplementation remains unchanged year after year: nothing noticeably improves. Energy, immunity, cognitive clarity, skin quality, and sleep all plateau at the same level they were at before the bottles were opened. The explanation is rarely that supplements don't work. It is almost always that the specific supplement chosen was not calibrated to the specific nutritional gap that actually exists in the specific person who purchased it. This is the clinical failure of the generic multivitamin — and it is the problem that personalised vitamins Australia-wide has emerged to solve.

The personalised nutrition model is not a marketing concept. It is grounded in a straightforward scientific principle: different people have different nutritional gaps, driven by their age bracket, dietary pattern, physiological stress load, hormonal stage, medication history, genetic variants in nutrient metabolism, and specific health priorities. A formulation designed for a hypothetical average adult provides subtherapeutic doses of the nutrients that person most needs, excess coverage of the nutrients they already obtain from diet, and frequently the wrong ingredient forms for the absorption impairments most prevalent in their demographic. The alternative — a protocol that maps your specific profile to the specific TGA AUST L-listed formulations and doses that the clinical evidence supports for your actual biological context — produces outcomes that a generic product cannot, because it is addressing the gaps that actually exist rather than the statistical average of gaps across a population.

This guide explains the clinical basis for personalised supplementation, how Zenutri's evidence-based personalisation process works, what to look for in any personalised vitamins Australia provider, and why every Zenutri formulation — across all seven TGA AUST L-listed products — was designed to be both independently evidence-based and intelligently combinable within a personalised protocol framework.

The Clinical Case Against Generic Multivitamins

The fundamental problem with the generic multivitamin is not that it contains the wrong ingredients in principle — most generic multivitamins include vitamin D, zinc, magnesium, B-vitamins, and Vitamin C, all of which are clinically important. The fundamental problem is that it contains the wrong forms of those ingredients at the wrong doses for most of the people who take it. These are not subtle quality differences. They are differences that determine whether a supplement changes anything at the cellular level or produces nothing beyond an improved urine nutrient profile.

The magnesium example illustrates this most clearly. The NHMRC 2017 Nutrient Reference Values identify magnesium insufficiency as prevalent in approximately one in three Australian adults based on dietary intake data. A generic multivitamin typically provides 50 to 100mg of magnesium as magnesium oxide — the cheapest available form with a documented intestinal absorption rate of approximately 4 percent, as confirmed by Gröber and colleagues in the 2015 comprehensive review in Nutrients. The 4 percent absorption rate means a product labelling 100mg of magnesium oxide delivers approximately 4mg of absorbed elemental magnesium. This quantity provides no meaningful contribution to the 300 to 400mg of bioavailable magnesium that the clinical evidence for sleep quality, nervous system regulation, and mitochondrial energy function requires. The person taking this supplement is not receiving insufficient magnesium because the formulation was careless. They are receiving insufficient magnesium because the formulation was optimised for shelf-life and manufacturing cost rather than for the clinical outcome it nominally claims to support.

The same form-and-dose analysis applies across the spectrum of generic multivitamin ingredients. Zinc as zinc oxide at 5mg versus zinc glycinate at 20mg (Gandia 2007, International Journal for Vitamin and Nutrition Research — superior pharmacokinetics of glycinate form). Vitamin E as synthetic dl-alpha-tocopherol versus natural mixed tocopherols (Jiang 2001, American Journal of Clinical Nutrition — gamma-tocopherol's distinct anti-inflammatory mechanism absent from synthetic form). Vitamin B12 as cyanocobalamin requiring hepatic conversion versus methylcobalamin as the active coenzyme directly available for neurological and methylation cycle use. Vitamin K as K1 (phylloquinone) versus K2 MK-7 — K2's specific activation of osteocalcin and matrix Gla protein for bone and cardiovascular calcium regulation confirmed by the Knapen 2013 randomised controlled trial in Osteoporosis International. In every case, the inferior form is the cheaper form — and generic multivitamin formulations are systematically optimised for manufacturing cost rather than for the clinical outcomes the label implies. This is the clinical foundation for the personalised vitamins Australia movement, and it is the problem that a genuinely evidence-based personalised protocol framework is specifically designed to solve. To see how your specific profile maps to the right protocol, take the Zenutri personalised health quiz now.

The Nutrient Gap Varies by Individual — Which Is Why Personalisation Matters

Beyond the form and dose problem, the identity of the most significant nutritional gap varies considerably between individuals in ways that a single generic formulation cannot address. A 38-year-old woman with a high-stress professional career and a plant-dominant dietary pattern has a very different nutritional priority profile than a 52-year-old man on statin medication with a mixed dietary pattern and a family history of cardiovascular disease. The first profile's most significant gaps are likely magnesium (stress depletion), iron (women of reproductive age), zinc (phytate inhibition in plant-based diets), B12 (plant-based diets), and Vitamin D (sun avoidance). The second profile's most significant gaps are likely CoQ10 (statin-mediated HMG-CoA reductase inhibition), Vitamin D, K2 (cardiovascular calcium regulation), and NAD+ precursors (age-related decline). A product designed for the "average adult" provides a partial, sub-optimal response to both of these profiles while potentially providing unnecessary coverage of nutrients that are not deficient in either. Personalised supplementation maps the specific gaps of the specific individual to the specific formulations designed to address them.

How Personalised Supplementation Works: The Evidence-Based Protocol Framework

A genuine personalised vitamins Australia protocol is not produced by a quiz that assigns everyone with "fatigue" to the same combination of B-vitamins and ginseng. It is produced by a structured assessment process that identifies the specific nutritional, physiological, and lifestyle variables that determine which nutrient gaps are most clinically significant for a given individual, and maps those variables to formulations with the ingredient forms, doses, and safety profiles that the clinical evidence supports for those specific gaps.

The variables that drive the most clinically significant nutritional differences between Australian adults fall into four categories. Life stage: the NHMRC 2017 Nutrient Reference Values identify substantially different requirements for iron, folate, calcium, D3, K2, and CoQ10 across the 18 to 34, 35 to 44, 45 to 59, and 60+ age brackets — and these differences are large enough to make a protocol appropriate for a 28-year-old clinically inadequate for a 52-year-old in the same gender category. Dietary pattern: plant-dominant diets create specific and predictable gaps in B12, iron, zinc, DHA, and selenium that omnivorous diets with regular animal-product consumption partially address; high-grain- or legume-dominant patterns create phytate-driven challenges to zinc and iron absorption, even at adequate nominal intakes. Medication history: statins deplete CoQ10 through HMG-CoA reductase inhibition; proton pump inhibitors impair B12, magnesium, and calcium absorption; metformin impairs B12 absorption through a calcium-dependent ileal mechanism. Specific health priorities: bone density maintenance requires D3 and MK-7 (K2) at the doses validated by the Knapen 2013 MK-7 RCT; cognitive performance support requires DHA and B-complex in activated forms; cellular energy and longevity support require the four-pathway NAD+/CoQ10/antioxidant/bone protocol that Zenutri's Longevity Plus Bundle addresses. Personalisation produces optimal outcomes precisely because it maps these four variable categories to the formulation decisions they clinically require.

Why Consistent Daily Delivery Compounds the Personalisation Advantage

The clinical evidence for every nutrient in the Zenutri range was generated in trials using consistent daily dosing maintained over weeks to months — because the biological outcomes that nutritional supplementation supports (bone mineralisation, mitochondrial efficiency, cellular NAD+ restoration, immune mineral repletion) operate on cumulative timelines that require sustained, uninterrupted tissue-level exposure. The pre-sorted daily sachet delivery model that Zenutri uses is therefore not a packaging convenience — it is the delivery mechanism that makes the consistency the clinical evidence requires achievable within the context of a busy, high-demand Australian adult life. Research on health behaviour consistency confirms that simplified, low-friction delivery formats significantly improve adherence rates for daily supplement protocols — which is why reducing the cognitive and logistical load of managing multiple individual supplement bottles directly improves the probability of achieving the sustained dosing the clinical evidence requires.

What Genuine Quality Looks Like: TGA Regulation and the Four Markers That Matter

The Australian personalised vitamins market has grown substantially, and as with any expanding wellness category, product quality varies significantly between providers. Understanding the four markers that define genuine clinical quality allows any provider to be evaluated objectively — regardless of the sophistication of their quiz technology, the design quality of their packaging, or the warmth of their brand voice.

Marker One: TGA AUST L Registration on Every Individual Product

Australia's Therapeutic Goods Administration classifies vitamins and supplements as therapeutic goods under the Therapeutic Goods Act 1989 — a regulatory framework that is substantially more stringent than the food-category treatment of supplements in the United States and most other markets. Every product sold as a therapeutic good in Australia must carry an AUST L (listed) or AUST R (registered) number, confirming that the product is entered in the Australian Register of Therapeutic Goods (ARTG), that each ingredient is on the TGA's permitted list for listed medicines, and that the manufacturing facility is TGA-licensed to current Good Manufacturing Practice (cGMP) standards. The critical nuance: the AUST L listing should apply to each individual product in a personalised pack — not to a catch-all bundle registration that covers a package but not the individual formulations within it. Every Zenutri formulation carries its own discrete AUST L number: C E B Optima (521487), CurcuNova (520796), Immunaxis (521494), MagLipo Core (520793), Osteo+Core (520792), Reversa NR (520794), and UbiQ Forte (520795). Each can be independently verified on the TGA ARTG database.

Marker Two: Individually Disclosed Ingredient Forms and Milligram Quantities

A personalised vitamins provider that cannot tell you the specific form (magnesium glycinate not "magnesium," zinc glycinate, not "zinc," methylcobalamin not "Vitamin B12," MK-7, not "Vitamin K2") and the individual milligram quantity of every active ingredient in your daily pack is withholding the information required to assess whether the protocol is clinically adequate. Proprietary blends — aggregate ingredient groupings with a single total weight that conceals individual quantities — are the format that makes label-dusting invisible. A provider built around clinical outcomes discloses every ingredient form and quantity individually, because the formulations can withstand that scrutiny. A provider built around marketing aesthetics conceals the details that would reveal the gap between the clinical claims on the label and the doses inside the capsule.

Marker Three: Pharmaceutical cGMP Australian Manufacture

TGA cGMP manufacturing requires batch-by-batch identity testing of raw ingredients, potency verification of finished products, contamination screening for heavy metals and microbial load, equipment calibration documentation, and stability testing across the product's shelf life. This is the manufacturing standard that ensures the 150mg of nicotinamide riboside stated on a Reversa NR label is present in the capsule in the stated form, at the stated concentration, in every batch. Australian manufacture also provides the supply chain transparency, the shorter transit pathway for chemically sensitive actives (NR, CoQ10, MK-7), and the environmental manufacturing standard oversight that offshore manufacturing contexts cannot consistently guarantee. When a personalised vitamins Australia provider states "Australian-made" — confirm this means manufactured in a TGA-licensed Australian facility, not imported and packaged in Australia.

Marker Four: A Personalisation Process Grounded in Clinical Evidence, Not Lifestyle Aesthetic

The quality of a personalised nutrition assessment is ultimately determined by whether the outputs map to formulations with clinical evidence for the outcomes being targeted, at doses that match the evidence, in forms with demonstrated absorption at those doses. A quiz that assigns "high stress" to an adaptogen blend at 50mg ashwagandha without a dose-efficacy reference point is not clinically grounded — it is lifestyle marketing in quiz format. A quiz that maps "high stress + poor sleep + 45-year-old woman" to magnesium amino acid chelate at 300mg+ (Gröber 2015), methylcobalamin B12 (MTHFR consideration), Vitamin D3 at 1,000 IU (ABS prevalence of insufficiency), and MK-7 K2 at 180mcg (Knapen 2013 bone RCT) is translating clinical evidence into personalised protocol recommendations. The difference is evident in the specificity with which the provider can explain why each formulation in a recommended protocol was chosen — including named ingredients, forms, doses, and the clinical evidence supporting each decision.

The Zenutri Modular System: Seven Products, Infinite Protocol Combinations

Zenutri's seven TGA AUST L-listed formulations were designed as a modular system — each independently evidence-based for its specific biological pathway, each combinable with the others without creating problematic nutrient overlaps, and each calibrated against the NHMRC 2017 Nutrient Reference Values safe upper intake levels when used in combination. This modularity is what allows the Zenutri personalisation system to produce genuinely individualised protocols across the full range of Australian adult health profiles rather than cycling through a limited menu of pre-defined "wellness bundles."

C E B Optima (AUST L 521487) provides Vitamin C at 250mg for collagen synthesis co-factor support and antioxidant recycling (Lykkesfeldt & Tveden-Nyborg, Nutrients 2019), natural mixed tocopherols at 70mg for the gamma-tocopherol-inclusive antioxidant protection that synthetic alpha-tocopherol cannot provide (Jiang 2001, AJCN), and nicotinamide (B3) alongside a B-complex for cellular energy metabolism support. This is the foundational antioxidant and B-complex layer that benefits virtually all adult profiles.

Immunaxis (AUST L 521494) provides zinc glycinate at 20mg (Gandia 2007, IJVNR — superior pharmacokinetics), selenomethionine at 100mcg (Toulis 2010, Thyroid — highest bioavailability selenium form), and Vitamin A at 900mcg RE for the immune mineral triad that T-lymphocyte maturation, glutathione peroxidase antioxidant defence, and mucosal immune barrier function require simultaneously.

MagLipo Core (AUST L 520793) provides elemental magnesium at 55mg as an amino acid chelate (Gröber 2015, Nutrients — the form confirmed superior to oxide in absorption and tolerability) alongside alpha-lipoic acid at 150mg as the mitochondrial co-factor for the pyruvate dehydrogenase complex (Packer 1998, Free Radical Biology and Medicine). This formulation specifically addresses the prevalent magnesium insufficiency among Australian adults, alongside the mitochondrial energy cofactor support that midlife professionals benefit most from.

Osteo+Core (AUST L 520792) provides Vitamin D3 at 1,000 IU and MK-7 K2 at 180mcg — the precise dose validated by the Knapen 2013 three-year RCT in Osteoporosis International for bone mineral density improvement, and the K2 form linked by the Geleijnse 2004 Journal of the American College of Cardiology cohort study to a 57 percent reduction in cardiac mortality through matrix Gla protein activation and arterial calcium regulation. The D3 and K2 co-formulation is prioritised for women over 40, men over 50, and adults with low sun exposure or assessed Vitamin D insufficiency.

Reversa NR (AUST L 520794) provides nicotinamide riboside at 150mg — the most clinically validated NAD+ precursor, confirmed by the Brenner 2018 Nature Communications human trial to raise blood NAD+ levels by 40 to 90 percent — alongside resveratrol for SIRT1 activation, magnesium amino acid chelate for NAD+ biosynthesis pathway co-factor support, and BioPerine-standardised piperine at 6.95mg for enhanced systemic absorption. This formulation is prioritised for adults over 35 seeking cellular energy restoration and longevity pathway activation.

UbiQ Forte (AUST L 520795) provides CoQ10 at 150mg — the minimum effective dose identified by the Fotino 2013 meta-analysis in AJCN for meaningful cardiovascular and metabolic outcomes, and the dose used in the Mortensen 2014 Q-SYMBIO trial that demonstrated a 43 percent reduction in major adverse cardiovascular events. UbiQ Forte is specifically prioritised for users of statin medications (CoQ10 synthesis is suppressed by HMG-CoA reductase inhibition), adults over 40 with cardiovascular risk factors, and individuals with established mitochondrial energy impairment.

CurcuNova (AUST L 520796) provides curcumin from Curcuma longa extract at a 20:1 concentration, resveratrol at 150mg, an activated B-complex, and BioPerine-standardised piperine at 13.9mg — the piperine co-factor that the Shoba 1998 Planta Medica pharmacokinetic study confirmed increases curcumin bioavailability by 2,000 percent through UGT and CYP3A4 inhibition. CurcuNova addresses the NF-κB-mediated inflammatory signalling, SIRT1 activation through resveratrol, and cellular antioxidant protection pathways that are most relevant for adults managing high physiological stress loads and seeking comprehensive longevity support. Note: CurcuNova contains piperine and carries a curcumin liver warning — individuals on antidepressant medication (CYP3A4 consideration) or with hepatic conditions should discuss initiation with their GP.

How the Zenutri Health Quiz Builds Your Personalised Protocol

The Zenutri health quiz is the clinical decision-support tool that translates your profile across the four variable categories — life stage, dietary pattern, medication history, and health priorities — into a Zenutri formulation recommendation, with a clinical-evidence rationale for every product inclusion. It accounts for the age-bracket product sets that reflect the NHMRC 2017 life-stage nutrient reference values, the safety exclusions that apply to specific health conditions and medication combinations (warfarin and UbiQ Forte/Osteo+Core K2, antidepressants and CurcuNova piperine, shellfish allergy and CurcuNova levomefolate), and the priority-weighting that ensures the most clinically significant gaps for your profile are addressed first within a manageable protocol.

The quiz process takes approximately five minutes and produces a recommendation with individual product rationales that explain in plain language why each formulation was selected for your specific profile — not a generic "good for everyone" justification, but a specific connection between your stated health context and the clinical evidence for the selected product at the recommended dose. This transparency is the mechanism through which Zenutri's personalisation process is differentiated from quiz-formatted upselling: every recommendation connects to a specific clinical claim that can be verified against the published research linked throughout this article and the broader Zenutri blog series.

The Protocol for Different Australian Adult Profiles

To illustrate how the modular system produces different protocols for genuinely different profiles, consider three representative Australian adult scenarios. A 32-year-old woman on a plant-dominant diet with high cognitive demands and irregular sleep: the evidence-aligned protocol prioritises Immunaxis (zinc glycinate for immune and hormonal support; selenomethionine for antioxidant and thyroid function), C E B Optima (B-complex and Vitamin C for collagen and antioxidant support), and MagLipo Core (magnesium amino acid chelate for sleep quality and stress response). A 47-year-old man on statin therapy with cardiovascular risk factors and midlife fatigue: the evidence-aligned protocol prioritises UbiQ Forte (CoQ10 at 150mg for statin-induced depletion correction and mitochondrial ATP support), Osteo+Core (D3 and K2 for cardiovascular calcium regulation), and Reversa NR (NAD+ biosynthesis restoration for the mitochondrial efficiency decline characteristic of midlife). A 54-year-old woman in perimenopause seeking comprehensive longevity support: the evidence-aligned protocol encompasses the full Zenutri Longevity Plus Bundle — Reversa NR, UbiQ Forte, CurcuNova, and Osteo+Core — providing the complete four-pathway cellular energy, antioxidant signalling, and bone mineralisation support that the perimenopausal transition creates the most urgent simultaneous demand for across all four systems.

The Value Proposition: Why Targeted Quality Beats Generic Volume

The comparison between a generic supermarket multivitamin at A$15 per month and a targeted Zenutri protocol at A$3 to A$5 per day is often framed as a price comparison. It is more accurately framed as a clinical utility comparison. A A$15 multivitamin providing magnesium oxide at 4 percent absorption, zinc oxide with poor gut tolerability at sub-therapeutic doses, and synthetic cyanocobalamin B12 requiring hepatic conversion is not a cheaper version of a A$4 daily Zenutri protocol providing magnesium amino acid chelate, zinc glycinate at 20mg, and a full activated B-complex at therapeutic doses in TGA-verified Australian cGMP manufacture. It is a product that produces no meaningful clinical outcome at any price point — because the form, dose, and quality standard required to produce that outcome are not present. The relevant comparison is not the purchase price of the two products. It is the cost per unit of clinical outcome delivered — and by that measure, a sub-therapeutic, poorly absorbed product at any price is the more expensive choice.

Your Personalised Vitality Protocol Starts With Understanding Your Gaps

The era of one-size-fits-all supplementation is not ending because consumers have become more sophisticated about wellness marketing. It is ending because the clinical evidence for the form-, dose-, and individual-profile-specific nature of nutritional gaps has become too clear to ignore. Your nutritional gaps are not the statistical average of Australian adult nutritional gaps. They are the product of your specific age, dietary pattern, medication history, physiological stress load, and health priorities — and they require a protocol calibrated to those specifics, not one calibrated to a hypothetical average person who does not exist.

Zenutri's seven TGA AUST L-listed formulations represent the most comprehensive, evidence-grounded personalised vitamins Australia system currently available — with every ingredient form traceable to a pharmacokinetic or bioavailability study, every dose traceable to a clinical trial, every product individually TGA-registered, and every combination assessed against the NHMRC safe upper intake limits that ensure the protocol's safety at the individual and combined level. The health quiz that generates your personalised recommendation is free, takes five minutes, and produces a protocol rationale that you can verify against the research links embedded throughout this article and across the Zenutri blog series.

Ready to replace the generic multivitamin with a protocol that is actually calibrated to your biology? Take the free Zenutri health quiz and receive your personalised evidence-based protocol recommendation.

Your nutritional gaps are specific. Your protocol should be too.

Frequently Asked Questions

What is the difference between personalised vitamins and a standard multivitamin?

A standard multivitamin is formulated for a hypothetical average adult — providing a broad spectrum of nutrients at doses calculated to prevent deficiency in the general population, with ingredients chosen for manufacturing cost rather than absorption efficiency. A personalised vitamin protocol is built from your specific profile: your age bracket, dietary pattern, medication history, health history, and specific health goals. It uses the nutrients most likely to be insufficient in your individual context, in the bioavailable forms the pharmacokinetic evidence supports (zinc glycinate rather than zinc oxide, methylcobalamin rather than cyanocobalamin, MK-7 rather than MK-4), at doses that match the clinical evidence for the outcomes being targeted rather than the minimum to prevent named deficiency. The clinical difference is between a protocol that addresses the actual gaps in your specific biology and one that addresses a statistical approximation of the gaps in a hypothetical average person.

How does the Zenutri health quiz determine which supplements I need?

The Zenutri health quiz maps your responses across four variable categories — life stage and age bracket, dietary pattern, medication history, and specific health priorities — to the clinical evidence for nutritional gaps and the Zenutri formulations most directly supported by that evidence for your specific profile. The algorithm accounts for the NHMRC 2017 Nutrient Reference Value life-stage differences that create different priority formulations at different ages, the safety exclusions that apply to specific health conditions and medication combinations (documented throughout the Zenutri product formulation decisions), and the evidence-based priority weighting that ensures the most clinically significant gaps for your profile are addressed first. The output includes individual product rationales explaining why each formulation was selected for your specific context — not generic "good for wellness" claims.

Why does ingredient form matter so much in personalised vitamins?

Ingredient form determines bioavailability — the proportion of a stated dose that actually reaches systemic circulation and target tissues. Magnesium oxide has a documented absorption rate of approximately 4 percent (Gröber 2015, Nutrients), meaning 100mg on the label delivers approximately 4mg to the bloodstream. Magnesium glycinate achieves substantially higher absorption through a carrier-mediated amino acid transport pathway. Zinc glycinate is pharmacokinetically superior to zinc sulphate or zinc oxide (Gandia 2007, IJVNR). Natural mixed tocopherols provide the gamma-tocopherol isomer that synthetic dl-alpha-tocopherol lacks (Jiang 2001, AJCN). Methylcobalamin is available for immediate cellular use without the hepatic conversion that cyanocobalamin requires. MK-7 K2 has a 72-hour plasma half-life, enabling once-daily dosing, while MK-4 requires multiple daily doses at much higher amounts. In every case, the superior form is more expensive to manufacture — which is why generic products systematically use inferior forms, and why form verification is the primary quality assessment that the milligram count alone cannot provide.

What does the TGA AUST L listing actually guarantee about a personalised vitamins product?

An AUST L listing confirms three things that are non-negotiable for any therapeutic supplement: the product is manufactured in a TGA-licensed facility operating under current Good Manufacturing Practice (cGMP) standards, meaning batch-by-batch identity testing, potency verification, contamination screening, and documented production records; the ingredients are on the TGA's permitted list for listed medicines at the stated doses; and the label accurately reflects the contents, as the manufacturer has declared to the TGA and is subject to audit verification. What it does not confirm is therapeutic efficacy at the stated dose — the TGA assesses safety and quality for listed medicines, not pre-market efficacy. This is why the AUST L listing is the necessary regulatory foundation, but the dose and the form of the ingredient require independent clinical evaluation alongside it. All seven Zenutri formulations carry individual AUST L listings verifiable on the TGA ARTG database.

How long should I commit to a personalised vitamin protocol before assessing whether it's working?

The 90-day window is the minimum biologically justified assessment period for most nutritional supplementation outcomes. This encompasses the cellular renewal timelines that determine when nutrient repletion becomes visible and measurable: red blood cell production (30 to 60 days for haematological normalisation), epidermal cellular turnover (28 to 40 days), hair follicle cycling (90 days minimum for quality changes), blood NAD+ stabilisation (Brenner 2018 — significant elevation at 60 days), and CoQ10 tissue saturation (Fotino 2013 — cardiovascular outcomes at 8 to 12 weeks). Energy and sleep improvements are typically the earliest measurable signals, often noticeable within 30 days. At the 90-day mark, the Zenutri health quiz can be retaken to reassess whether the protocol remains correctly calibrated to your current biology — ensuring your personalised vitamins remain genuinely personalised as your life stage and health context evolve.

Can I combine multiple Zenutri formulations safely?

All Zenutri formulations are designed to be combinable within the safe upper intake levels established by the NHMRC 2017 Nutrient Reference Values. The primary cumulative intake considerations are selenium (Immunaxis provides 100mcg selenomethionine; ensure combined selenium from all products and diet stays below 400mcg daily safe upper limit), zinc (Immunaxis provides 20mg zinc glycinate; combined zinc from all supplements should remain below the 40mg/day copper competition threshold), and the fat-soluble vitamins D3 and K2 (Osteo+Core provides 1,000 IU D3 and 180mcg MK-7, within the 4,000 IU D3 and without a K2 upper limit concern at this dose). For individuals combining three or more Zenutri formulations or adding their existing multivitamin, the Zenutri health quiz accounts for these cumulative intake calculations in its protocol recommendations. GP consultation is appropriate if you are managing a chronic health condition or taking prescription medications, specifically regarding the warfarin interaction for UbiQ Forte and Osteo+Core, and the CYP3A4 consideration for CurcuNova in individuals on antidepressant therapy.